Kingdon David Graham, Kirschen Holly
Mental Health Group, Royal South Hants Hospital, University of Southampton, Brintons Terrace, Southampton, Hampshire, SO14OYG United Kingdom.
Psychiatr Serv. 2006 Dec;57(12):1792-4. doi: 10.1176/ps.2006.57.12.1792.
The evidence base for using cognitive-behavioral therapy in schizophrenia is well established; it is recommended in guidelines by the Schizophrenia Patient Outcomes Research Team.
Data were examined regarding referral patterns for patients with schizophrenia who were seen by one of four psychiatrists at the mental health center providing services to West Southampton (England).
Of the 142 patients identified, 69 had and 73 had not been referred for cognitive-behavioral therapy. Patients tended not to be referred if they were considered to be doing well and not in need of therapy or were unlikely to engage.
In a location where cognitive-behavioral therapy for schizophrenia was readily available, half of all patients were considered appropriate for referral. Improved engagement skills and more assertive outreach by therapists and consideration by referrers of the benefits of relapse prevention might bring the benefits of cognitive-behavioral therapy to a still broader group.
在精神分裂症中使用认知行为疗法的证据基础已得到充分确立；精神分裂症患者结局研究团队的指南中推荐了该疗法。
对英格兰南安普敦西部心理健康中心的四位精神科医生之一诊治的精神分裂症患者的转诊模式数据进行了检查。
在确定的142名患者中，69名被转诊接受认知行为疗法，73名未被转诊。如果患者被认为情况良好且不需要治疗或不太可能参与治疗，则往往不会被转诊。
在一个精神分裂症认知行为疗法容易获得的地方，所有患者中有一半被认为适合转诊。治疗师提高参与技能、更积极主动地开展外展服务，以及转诊者考虑预防复发的益处，可能会使更广泛群体受益于认知行为疗法。
